Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.95), $0.06 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.